- Research Article
- 10.1016/j.injury.2026.113195
Encouraging recovery or avoiding risk? A proposed clinical framework for rehabilitation decision-making after fragility fractures.
- Jun 01, 2026
- Injury
- Mariam A Ibrahim + 5 more +5
Publications from 2021 to 2026
Showing 10 of 472 papers
Encouraging recovery or avoiding risk? A proposed clinical framework for rehabilitation decision-making after fragility fractures.
Training satisfaction among medical trainees in the Ministry of defense, fifth training sector, KSA.
Pre-Clinical Models of Traumatic Brain Injury-A Narrative Review Towards "Animal Neuro-ICUs".
The presence of traumatic brain injury (TBI) is a critical determinant of post-traumatic mortality and morbidity. Not only is TBI one of the leading causes of death among severely injured patients, but it also substantially impacts long-term outcomes following severe trauma. Neurocritical care has a profound effect on outcomes following brain injury; nevertheless, its application in preclinical studies remains infrequent. This review therefore discusses strategies to improve the translational relevance of experimental TBI research, including the integration of neurocritical care principles in animal models. The review further addresses the impact of observation periods after injury and the selection of appropriate animal models (large vs. small animal models). In addition, commonly used injury induction methods-including controlled cortical impact (CCI), fluid percussion injury (FPI), weight-drop models, and blast injury paradigms-are discussed in terms of their reproducibility and clinical relevance. Finally, the review explores whether age, comorbidities, and sex influence TBI outcomes-and, if so, how these variables should be incorporated into experimental designs to improve translational fidelity.
Read moreCongenital Chylous Ascites in a Neonate with Isolated Aqueductal Stenosis: A Case Report and Literature Review.
Background and Clinical Significance: Ventriculoperitoneal (VP) shunting remains the standard definitive treatment for progressive neonatal obstructive hydrocephalus. Congenital chylous ascites is an uncommon neonatal condition, most often related to developmental lymphatic abnormalities. The concurrence of hydrocephalus requiring VP diversion with congenital chylous ascites is exceptionally rare and may first become apparent during abdominal access for shunt placement. Awareness of this possibility is clinically important because milky peritoneal fluid at shunt surgery can mimic gastrointestinal injury, and persistent postoperative abdominal fluid collections may be misattributed to shunt-related complications. Case Presentation: A late-preterm female infant (36 weeks' gestation; birth weight 2.3 kg) presented with congenital hydrocephalus. Cranial ultrasonography was consistent with isolated aqueductal stenosis. Preoperative abdominal ultrasonography demonstrated mild ascites. On 27 May 2025, a VP shunt was placed for obstructive hydrocephalus. Upon entering the peritoneal cavity, milky-white fluid was encountered, prompting concern for bowel injury; however, careful exploration showed no gastrointestinal perforation. Ascitic fluid analysis revealed markedly elevated triglycerides (2300 mg/dL), confirming chylous ascites. The VP shunt was completed without an intraoperative complication. During follow-up, the infant showed appropriate growth (weight 3.0 kg; length 50 cm), while ascites persisted, and she was referred for multidisciplinary evaluation and management. Conclusions: This case highlights an exceptionally rare association of congenital chylous ascites with isolated aqueductal stenosis, identified incidentally during VP shunt insertion. Prompt intraoperative recognition, biochemical confirmation, and coordinated follow-up are essential to distinguish congenital chylous ascites from shunt-related abdominal fluid collections and to guide appropriate multidisciplinary care.
Read moreThe Effects of Sertraline on Dialysis-Induced Hypotension: A Systematic Review and Meta-Analysis.
Background/Objectives: Dialysis-induced hypotension (DIH) affects 10-30% of hemodialysis sessions and increases mortality. Sertraline may stabilize blood pressure by modulating the Bezold-Jarisch reflex. We aimed to evaluate the efficacy and safety of sertraline for preventing DIH. Methods: We searched PubMed, EMBASE, Cochrane Library, and ClinicalTrials.gov through December 2025. Random-effects meta-analysis was performed using standardized mean differences (SMD). Results: Nine studies (140 patients) met inclusion criteria. Sertraline significantly increased mean arterial pressure (SMD: 0.87; 95% CI: 0.52-1.22; p < 0.001), corresponding to approximately 8.5 mmHg. DIH episodes decreased by 35% (RR: 0.65; 95% CI: 0.48-0.88). Heterogeneity was moderate (I2 = 42%). Among studies reporting safety data (n = 106), adverse events were mild (14%) with no serious events. No publication bias was detected (Egger's p = 0.21). Conclusions: Sertraline significantly improves hemodynamic stability during hemodialysis with a favorable safety profile. It represents a promising option for DIH, particularly in patients with comorbid depression or contraindications to midodrine.
Read moreBiomechanical comparison of triangular osteosynthesis and triangular minimally invasive spinopelvic stabilization technique for pelvic fragility fractures.
Summary of Research: Safety and Effectiveness of Concomitant iGlarLixi and SGLT-2i Use in People with T2D During Ramadan Fasting: A SoliRam Study Sub-analysis.
This is a summary of the original article "Safety and effectiveness of concomitant iGlarLixi and SGLT-2i use in people with T2D during Ramadan fasting: a SoliRam study sub-analysis." iGlarLixi is a fixed-ratio combination of insulin glargine 100U/ml and glucagon like peptide1 receptor agonist (GLP-1RA) lixisenatide which has demonstrated its effectiveness of improving glycemic parameters and reducing body weight with low risk of hypoglycemia incidence in adults with type2 diabetes (T2D) who were previously sub-optimally controlled with oral antidiabetic drugs (OADs) alone or in combination with basal insulin or GLP-1RA. This sub-analysis of the SoliRam study assessed the safety and effectiveness of concomitant iGlarLixi and sodium/glucose cotransporter2 (SGLT-2i) use with or without other OADs in adults with T2D who fasted during Ramadan. Participants were divided into two groups: SGLT-2i-users and SGLT-2i-non-users. The findings showed low incidence of severe and/or symptomatic documented hypoglycemia, improved glycemic control, and body weight benefits, irrespective of SGLT-2i use. No serious adverse events were reported in either group. The sub-analysis concluded that the concomitant iGlarLixi and SGLT-2i therapy, with or without other OADs, was demonstrated to be a safe treatment for people with T2D during Ramadan fasting.
Read moreComparative Effect of Ticagrelor and Clopidogrel on Left Ventricular Remodeling in Acute Coronary Syndrome Patients: A Retrospective Cohort Study.
Clinical Outcomes of Platelet-Rich Plasma in Otology: A Systematic Review of Tympanoplasty, Myringoplasty, and Hearing Loss Management
Platelet-rich plasma (PRP), an autologous concentrate of platelets and growth factors, has been explored as an adjunct in otologic procedures, including tympanoplasty, myringoplasty, and treatment of sudden sensorineural hearing loss (SNHL). This systematic review evaluated reported clinical outcomes associated with PRP in these settings. A literature search was conducted in March 2025 across PubMed, Scopus, Web of Science, EMBASE, and the Cochrane Library. Eligible studies were English-language human studies (2015-2025) with original clinical outcome data from randomized or comparative observational designs. Due to methodological heterogeneity, findings were synthesized narratively. Six studies (n = 349 patients) were included: five addressing tympanic membrane repair and one addressing idiopathic sudden SNHL. In myringoplasty/tympanoplasty-related studies, PRP was generally associated with higher graft uptake and/or faster healing than comparator approaches; where reported, closure outcomes included 85.7% versus 60% in one comparative study, and several studies reported between-group differences with p < 0.05. Reported postoperative complications were low, and no major PRP-related safety concerns were identified in the included studies. In SNHL, one comparative study suggested hearing improvement with intratympanic PRP that was comparable to, or greater than, steroid therapy, but evidence remains limited to short-term follow-up and a small number of studies. Current evidence supports PRP as a feasible and apparently safe adjunct in otologic practice, particularly for tympanic membrane repair. However, certainty regarding the magnitude of benefit and long-term auditory outcomes remains limited by small sample sizes, heterogeneity in PRP preparation/application, and variability in study design. Standardized protocols and larger, well-designed randomized trials are needed.
Read moreDNA Methylation Alterations in Benzene-Exposed Gasoline Station Workers: Insights from Singleplex MethyLight Analysis
Background & Objective: Alterations in global DNA methylation levels and repetitive elements are commonly observed in various cancers and in response to environmental pollutants, particularly petroleum products such as benzene. Long-term benzene exposure is harmful to human health and is associated with an increased risk of hematological malignancies. This study aimed to investigate the association between chronic occupational exposure to benzene and DNA methylation status in TGFβ2, MAGE-A1, and LINE-1 repetitive elements among gasoline station workers. Material and Methods: This case–control study included 30 male gasoline station workers and 30 male controls. Genomic DNA was extracted from peripheral blood samples using the QIAamp DNA Mini Kit (QIAGEN) and treated with sodium bisulfite via the EpiTect Fast DNA Bisulfite Kit. Singleplex MethyLight PCR was performed to assess methylation status of MAGE-A1, TGFβ2, and LINE-1. Results: Significant differences were observed in working hours (p = 0.004) and direct benzene exposure (p < 0.0001) between workers and controls. Percent MethyLight Reference (PMR) values were significantly different between the two groups for LINE-1 (p < 0.0001), TGFβ2 (p = 0.0194), and MAGE-A1 (p < 0.0001). Conclusion: Chronic benzene exposure is associated with altered DNA methylation patterns. Singleplex MethyLight analysis revealed significant PMR differences for MAGE-A1, LINE-1, and TGFβ2 between benzene-exposed workers and controls, highlighting the potential of DNA methylation profiling in occupational health risk assessment.
Read more